CHICAGO, IL / ACCESSWIRE / September 15, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), is a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that the Company's proprietary line of nutraceuticals, Sky Premium Life, has entered into an exclusive agreement with Mediprovita GbR. Mediprovita will begin selling its Sky Premium Life ("SPL") products in Germany and Austria beginning in the Fourth Quarter. The initial order for 20 SKUs will be sold through Amazon, Ebay, and Mediprovita's own ecommerce website. The Company expects to extend its relationship with Mediprovita in the near future to include the distribution of 70 SKU's.
Mediprovita is a full-service distributor and logistics provider of consumer products with over 30 years of experience. Cosmos has signed a distribution agreement with Mediprovita to be their exclusive distributor in Germany and Austria of the Sky Premium Life line. A proprietary, luxury and high-quality nutritional supplements' brand, with a complete range of vitamins, minerals, herbs, and unique formulas. Under the terms of the agreement, Mediprovita will employ its sales, marketing, and e-commerce expertise to distribute Sky Premium Life products throughout Germany and Austria. Aggelos Kiriazis, Mediprovita's CEO stated "Sky Premium Life products are a great fit for our business, as we began selling food supplements two years ago, with great success. Based on our comprehensive market research, we expect SPL products to have strong rate of acceptance in the German and Austrian markets."
"Our entry into Germany and Austria is an important step for us, as Germany has the largest Nutraceuticals market in Europe." stated Greg Siokas, Chief Executive Officer of Cosmos Health. "We are continuing our global roll-out strategy as we launch our products worldwide. Thus far in 2022, we have successfully introduced our products on Amazon in the United States, United Kingdom, Canada, and Singapore. Our key objective remains to grow internationally, as we continue to leverage our robust global logistics and distribution capabilities, while expanding our customer base worldwide."
According to Mordor Intelligence, the European nutraceutical market is expected to grow at a 7.5% CAGR to surpass $100 billion by 2027. Germany boasts the largest nutraceutical market within Europe at roughly 14%. Market expansion in Europe is attributed to the continued rising healthcare costs and an aging population.
Cosmos Health Inc. (Nasdaq:COSM) is a global healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. Cosmos Health is engaged in the nutraceuticals sector through its own proprietary lines of products "Sky Premium Life" and "Mediterranation." Additionally, the Company is operating in the pharmaceutical sector through the provision of a broad line of branded generics and OTC medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and UK serving retail pharmacies and wholesale distributors. Cosmos Health is strategically focused on the R&D of novel patented nutraceuticals (IP) and specialized root extracts as well as on the R&D of proprietary complex generics and innovative OTC products. Cosmos has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Health has offices and distribution centers in Thessaloniki and Athens, Greece and Harlow, UK. More information is available at www.cosmosholdingsinc.com and www.skypremiumlife.com.
With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company's ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic and the war in Ukraine, on the Company's business, operations and the economy in general, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's filings with the SEC, which are available at the SEC's website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact: Lytham Partners, LLC Ben Shamsian E: shamsian@lythampartners.com P: 646-829-9701
View source version on accesswire.com: https://www.accesswire.com/716018/Cosmos-Health-to-Launch-Sky-Premium-Life-Nutritional-Supplement-Products-in-Germany-and-Austria-via-Amazon-and-Ebay
Mizuho analyst Vijay Rakesh just lowered his price target on Nvidia, but if he's right it's a good buy from here.
In this article, we will take a look at the 10 Blue Chip Stocks to Buy Now According to Billionaire George Soros. To skip our analysis of George Soros’ profile, investment strategy, and 13F holdings, you can go directly to see the 5 Blue Chip Stocks to Buy Now According to Billionaire George Soros. George […]
Struggling Bed Bath & Beyond Inc. releases a list of dozens of stores it aims to close. Most of the stores on this list will close by the end of the month.
Amazon's founder and executive chairman was the world's richest man for several years before falling to second place.
Yahoo Finance Live anchors discuss stock performance for FedEx.
FedEx has blown three tires before the peak holiday shipping season, and chatter on the Street is that mighty Amazon may have played a role.
Central banks are like “reformed smokers,” famed investor Stanley Druckenmiller says. “They’ve gone from printing a bunch of money, like driving a Porsche at 200 miles an hour, to not only taking the foot off the gas, but just slamming the brakes on.”
NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.
Income investors are always on the hunt for good stocks that for one reason or another have recently been out of favor, creating a scenario for a higher dividend yield along with possible future appreciation as the stock bounces back. Buying a stock on a decline sometimes involves a bit of courage, but the ability to lock in long-term higher yields makes the decision easier for most investors. At the moment, Medical Properties Trust Inc. (NYSE: MPW), a Birmingham, Alabama-based real estate inves
After three months of highly volatile trading, which have seen the S&P 500 drop down toward 3,600, rally up to 4,300, and fall back down to 3,900, investors can be forgiven for feeling some whiplash. The question that needs answering, however, is where will the markets go from here? Morgan Stanley strategist Andrew Slimmon believes that investors shouldn’t worry too much about the bear case. Worse-than-expected inflation numbers for August may have pushed the markets into a tumble this week, but
Wall Street is on a roller coaster again, as investors try to navigate the path between high inflation and the Fed’s aggressive interest rate hikes. What we know for certain is that the S&P 500 is down 18% year-to-date, and the NASDAQ is down 26%. At least one investing expert, however, is getting on his soapbox to encourage investors to buy now, while prices are low. This is the view of Shark Tank investor Kevin O’Leary. The venture capitalist makes a case for investors to take advantage of vol
As bad the news was for FedEx, it may be worse news for the U.S. economy --- and an early sign of a recession.
It's no secret that investors are worried about runaway inflation. Cathie Wood and Elon Musk see deflation as the bigger threat.
There was no good news in the August inflation numbers. While the annualized rate did fall slightly from July, from 8.5% to 8.3%, it came in higher than expected – and worse, the core CPI rate, rather than dropping, increased to 6.3%. Consumers are struggling, and their pain is real. But it’s not only consumers who are getting hit hard by inflation. Retailers are also feeling the strain, and they’re feeling it twice – from consumers, whose wallets are pinched and so are buying less, and from the
Threadneedle Ventures Founder Ann Berry joins Yahoo Finance Live to discuss the FedEx warning, macroeconomic challenges, and the outlook for markets.
FedEx turned in poor earnings results and slashed its revenue forecast on Thursday as the company’s CEO warned that a “worldwide recession” is likely coming.
The Fed has no choice but to raise rates higher than the market expects, predicts billionaire investor Ray Dalio. Watch out stock investors.
Shares of enterprise software companies Datadog (NASDAQ: DDOG), Okta (NASDAQ: OKTA), and DocuSign (NASDAQ: DOCU) were plunging today, down 5.3%, 6%, and 7.2%, respectively, as of 2 p.m. EDT. Interest rates continued to rise this week after the fallout from Tuesday's inflation report. In addition, there have been several preannouncements from major companies that are hinting at a global recession.
Looking for high yield stocks in the finance sector? This pair of banks is worth close inspection, while this REIT is best avoided.
Pound sinks to lowest since 1985 as retail sales slump Germany seizes control of three Russian-owned Rosneft oil refineries FTSE 100 falls 0.6pc Ben Marlow: Shell must accept it has lost the battle on fossil fuels Sign up here for our daily business briefing newsletter